MedPath
NMPA Approval

Valsartan and Hydrochlorothiazide Tablets

国药准字H20244151

June 25, 2024

Drug Information

缬沙坦氢氯噻嗪片

片剂

每片含缬沙坦80mg,氢氯噻嗪12.5mg。

化学药品

June 25, 2024

Company Information

Applicant Company

珠海市金湾区三灶镇机场北路6号

Manufacturing Company

珠海市金湾区三灶镇机场北路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.